
Tenofovir Alafenamide Tablets, 25 mg, (RLD Vemlidy) had estimated annual sales of USD 531 million in the U.S. (IQVIA MAT…
Material improvement in Ebitda to be driven by topline growth
Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales…
The consolidated revenue advanced albeit marginally by 3.9 percent year-on-year (YoY) to Rs 4,322 crore in Q3FY23.
The tentative approval has been granted under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
The company claims that LYFE offers expert intervention in the form of dedicated care managers, health coaches and nutritionists.
Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of USD 666 million in the U.S.…
Prasugrel Tablets USP, 5 mg and 10 mg, (RLD Effient) had estimated annual sales of USD 18 million in the…
According to the pharma major, DIFIZMA will help in the management of inadequately controlled asthma by improving lung function, providing…
These labs are equipped with qualified clinical experts and automated, streamlined processes so patients can make informed decisions about their…
Some Biosimilar products help in increasing neutrophil counts of cancer patients, which helps to boost the immune system and reduce…
Spiro joins Lupin with significant experience in the branded, generic and biotech industries, the company stated.
According to IQVIA MAT October 2022, Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of USD…
According to IQVIA MAT October 2022, Rufinamide Tablets (RLD Banzel) had estimated annual sales of USD 138 million in the…
This move reinforces our commitment to making healthcare solutions accessible to all patients, the company claimed.
The company expects India to grow in double digits in FY2024
Meanwhile, global API Sales for Q2 FY2023 were INR 2,499 mn, down 2 percent as compared to INR 2,551 mn…
Doxycycline Capsules (RLD Oracea) had estimated annual sales of USD 215 million in the U.S., as per IQVIA MAT September…
Drospirenone Tablets (RLD Slynd) had estimated annual sales of USD 141 million in the United States, as per IQVIA MAT…
The pharma also announced that it expects the transaction to be accretive to earnings in the first year.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).
Loading…
Something went wrong. Please refresh the page and/or try again.